21 May 2009
Hypertension and cardiovascular disease in living kidney donors in Poland – one centre experience
M Bieniasz, A Kwiatkowski, P Domagała, R Kieszek, J Gozdowska, M Durlik, L Pączek, A Deptuła, J Trzebicki, P Pruszczyk, A ChmuraAnn Transplant 2009; 14(1): 50-50 :: ID: 880382
Abstract
Background: Living kidney donation is one of the few instances in medicine in
which a healthy individual undergoes a surgical intervention for the principal
benefit of someone else. The short-term complications of living donation are
infrequent, making it a safe procedure. However, the long-term risk of hypertension and cardiovascular disease remains uncertain. The aim of this study was to evaluate cardiovascular disease and hypertension in living kidney donors.
Material/Methods: A total of 66 living donor open nephrectomies were performed in the Department of General and Transplantation Surgery at the Warsaw Medical University between 1995 and 2005. Physical examination, blood and urine tests, ECG, ambulatory blood pressure measurement, cardiac echography and ophthalmoscopy were performed. Donor mean age was 40.9 years (range 29-60). The donors were predominantly female (52.5%). 27 donors did not report for follow-up visits. Observation period ranged from 36 to 156 months.
Results: Two patients (5.1%) were hypertensive before donation. One of them continued to had well-controlled hypertension after nephrectomy. Hypertensive angiopathy on ophthalmoscopy was observed in a 57-year old woman six years after donation. Ten patients (25.6%) developed hypertension after nephrectomy. Hypertension was observed in 14.3% (3/21) women and 38% (7/18) men. Cardiovascular disease (silent myocardial infarction) was observed in a 58-year old man. There was no mortality.
Conclusions: The risk of cardiovascular disease does not increase after living
kidney donation. The frequency of hypertension and cardiovascular disease
after living kidney donation is lower than in the general population.
Keywords: Kidney Transplantation, Living Donors
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






